Delivery Order SPE2DR25D2005-SPE2DR26FE8Y8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,505.17 to AmerisourceBergen Drug Corp for Trokendi XR 100 mg capsules (30-count packaging) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trokendi XR is a brand-name pharmaceutical product indicated for...
- The Defense Logistics Agency awarded a delivery order valued at $6,417.22 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count) on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,379.08 delivery order to AmerisourceBergen Drug Corp for Trokendi XR 100 mg capsules (30-count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. Trokendi XR is a brand-name neurological medication used primarily for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,248.46 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 50 mg capsules (30-count units) under a firm fixed-price contract. The award was made on December 10, 2025, with an ultimate completion date of December 11, 2025. This is an unset-aside, competitively awarded delivery order with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trokendi XR is a...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Trokendi XR 50 mg capsules (30-count packages) with a ceiling value of $1,803.93. This is a firm fixed price delivery order with an award date of July 14, 2025, and an ultimate completion date of July 15, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $6,530.33 delivery order to AmerisourceBergen Drug Corp for Trokendi XR 200 mg capsules (30-count packaging) under a firm fixed price contract type. The award was made on October 30, 2025, with an ultimate completion date of October 31, 2025, and no set-aside designation was used. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $25,401.53 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count units) under a firm fixed-price contract type. The award was made on November 6, 2025, with an ultimate completion date of November 7, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units) with a ceiling value of $12,939.63. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is set to be completed by April 30, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Trokendi XR 100 mg capsules (30-count) with a contract ceiling value of $5,466.97. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trokendi...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trokendi XR 100 mg capsules (30-count). The contract ceiling value is $1,304.52, with an ultimate completion date of May 13, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE8Y8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,003.28 to AmerisourceBergen Drug Corp for 30-count supplies of Trokendi XR 100 mg capsules. This is a firm fixed-price delivery order with an ultimate completion date of December 17, 2025, and represents a non-set-aside competitive award. The product will be delivered to the prime contractor's facility in Conshohocken, Pennsylvania. Trokendi XR is a brand-name anticonvulsant medication used for seizure management and migraine prevention, supporting the federal government's pharmaceutical supply chain for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical needs across multiple therapeutic domains through competitively awarded agreements with the Defense Logistics Agency and Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 12/15/25 |